Literature DB >> 16612569

Is the United States an outlier in health care and health outcomes? A preliminary analysis.

William S Comanor1, H E Frech, Richard D Miller.   

Abstract

U.S. health care is often seen as an outlier, with high costs and only middling outcomes. This view implies a household production function for health, with both health care and lifestyle serving as inputs. Building on earlier work by Miller and Frech (2004), we make this argument explicit by estimating a production function from augmented OECD data. This allows us to determine whether the U.S. is literally an outlier; which turns on whether the United States is very far off the production surface. We find that the Unites States is somewhat less productive than the average OECD country, but that a substantial part of the observed difference results from poor lifestyle choices, particularly obesity.

Entities:  

Mesh:

Year:  2006        PMID: 16612569     DOI: 10.1007/s10754-006-6863-8

Source DB:  PubMed          Journal:  Int J Health Care Finance Econ        ISSN: 1389-6563


  12 in total

1.  The effects of obesity, smoking, and drinking on medical problems and costs.

Authors:  Roland Sturm
Journal:  Health Aff (Millwood)       Date:  2002 Mar-Apr       Impact factor: 6.301

2.  National medical spending attributable to overweight and obesity: how much, and who's paying?

Authors:  Eric A Finkelstein; Ian C Fiebelkorn; Guijing Wang
Journal:  Health Aff (Millwood)       Date:  2003 Jan-Jun       Impact factor: 6.301

3.  It's the prices, stupid: why the United States is so different from other countries.

Authors:  Gerard F Anderson; Uwe E Reinhardt; Peter S Hussey; Varduhi Petrosyan
Journal:  Health Aff (Millwood)       Date:  2003 May-Jun       Impact factor: 6.301

4.  A skeptic's view of global budget caps.

Authors:  J M Poterba
Journal:  J Econ Perspect       Date:  1994

Review 5.  A guide to health care reform.

Authors:  D M Cutler
Journal:  J Econ Perspect       Date:  1994

6.  The rising prevalence of treated disease: effects on private health insurance spending.

Authors:  Kenneth E Thorpe; Curtis S Florence; David H Howard; Peter Joski
Journal:  Health Aff (Millwood)       Date:  2005 Jan-Jun       Impact factor: 6.301

7.  The disease burden associated with overweight and obesity.

Authors:  A Must; J Spadano; E H Coakley; A E Field; G Colditz; W H Dietz
Journal:  JAMA       Date:  1999-10-27       Impact factor: 56.272

8.  Annual deaths attributable to obesity in the United States.

Authors:  D B Allison; K R Fontaine; J E Manson; J Stevens; T B VanItallie
Journal:  JAMA       Date:  1999-10-27       Impact factor: 56.272

9.  The spread of the obesity epidemic in the United States, 1991-1998.

Authors:  A H Mokdad; M K Serdula; W H Dietz; B A Bowman; J S Marks; J P Koplan
Journal:  JAMA       Date:  1999-10-27       Impact factor: 56.272

10.  Primary prevention of coronary heart disease in women through diet and lifestyle.

Authors:  M J Stampfer; F B Hu; J E Manson; E B Rimm; W C Willett
Journal:  N Engl J Med       Date:  2000-07-06       Impact factor: 91.245

View more
  5 in total

Review 1.  The effects of pharmaceutical consumption and obesity on the quality of life in the organization of economic cooperation and development (OECD) countries.

Authors:  H E Frech; Richard D Miller
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

2.  Socialized medicine and mortality.

Authors:  Sam Peltzman
Journal:  Int J Health Care Finance Econ       Date:  2014-07-15

3.  Lessons for a national pharmaceuticals strategy in Canada from Australia and New Zealand.

Authors:  Jacques LeLorier; Nugek S B Rawson
Journal:  Can J Cardiol       Date:  2007-07       Impact factor: 5.223

4.  Improving life expectancy: how many years behind has the USA fallen? A cross-national comparison among high-income countries from 1958 to 2007.

Authors:  Stéphane Verguet; Dean T Jamison
Journal:  BMJ Open       Date:  2013-07-06       Impact factor: 2.692

5.  Comparing efficiency of health systems across industrialized countries: a panel analysis.

Authors:  Bianca K Frogner; H E Frech; Stephen T Parente
Journal:  BMC Health Serv Res       Date:  2015-09-25       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.